Diana Naranjo

Diana Naranjo PhD, Clinical Professor, Department of Pediatrics, Division of Endocrinology and Diabetes; Clinical Professor, Department of Psychiatry and Behavioral Sciences, Division of Child and Adolescent Psychiatry, Stanford University School of Medicine 

Research Description: Dr. Naranjo is co-investigator on NIH and foundation-funded clinical research aimed at overcoming barriers and increasing adherence in persons with diabetes. Two areas of emphasis cut across this work: 1) addressing health disparities in chronic illness through individual, provider, and systems level interventions, and 2) optimizing health and quality of life through medical devices and technologies. Beginning in postdoctoral fellowship and spanning the past 8 years, Dr. Naranjo investigated the unique behavioral, mental health, individual, and family factors that impact health care for youth with chronic illness, including T1D. In 2017, Dr. Naranjo received a SDRC Pilot and Feasibility Award.

Selected relevant publications (Stanford DRC Members in BOLD):

  1. Lum J, Bailey R, Barnes-Lomen V, Naranjo D, Hood K, Lal RA, Arbiter B, Brown A, DeSalvo DJ, Pettus J, Calhoun P, Beck RW. A Real-World Prospective Study of the Safety and Effectiveness of the Loop Open Source Automated Insulin Delivery System. Diabetes Technol Ther. 2020 Nov 23. doi: 10.1089/dia.2020.0535. PMID: 33226840. 

  2. Lanning M, Shen J, Wasser D, Riddle S, Agustin B, Hood K, Naranjo D. Exposure to Closed Loop Barriers Using Virtual Reality. J Diabetes Sci Technol. 2020 Sep;14(5):837-843. doi: 10.1177/1932296820902771. PMID: 32019329; PMCID: PMC7753868. 

  3. Barnard-Kelly KD, Naranjo D, Majidi S, Akturk HK, Breton M, Courtet P, Olié E, Lal RA, Johnson N, Renard E. Suicide and Self-inflicted Injury in Diabetes: A Balancing Act. J Diabetes Sci Technol. 2020 Nov;14(6):1010-1016. doi: 10.1177/1932296819891136. PMID: 31801353; PMCID: PMC7645123. 

  4. Tanenbaum ML, Iturralde E, Hanes SJ, Suttiratana SC, Ambrosino JM, Ly TT, Maahs DM, Naranjo D, Walders-Abramson N, Weinzimer SA, Buckingham BA, Hood KK. Trust in hybrid closed loop among people with diabetes: Perspectives of experienced system users. J Health Psychol. 2020 Mar;25(4):429-438. doi: 10.1177/1359105317718615. PMID: 28810490; PMCID: PMC7162558. 

  5. Iturralde E, Tanenbaum ML, Hanes SJ, Suttiratana SC, Ambrosino JM, Ly TT, Maahs DM, Naranjo D, Walders-Abramson N, Weinzimer SA, Buckingham BA, Hood KK. Expectations and Attitudes of Individuals With Type 1 Diabetes After Using a Hybrid Closed Loop System. Diabetes Educ. 2017 Apr;43(2):223-232. doi: 10.1177/0145721717697244. PMID: 28340542; PMCID: PMC7162535. 

  6. Wong JJ, Suttiratana SC, Lal RA, Lum JW, Lanning MS, Dunlap A, Arbiter B, Hanes SJ, Bailey RJ, Hood KK, Naranjo D. Discontinued Use of the Loop Insulin Dosing System: A Mixed-Methods Investigation. Diabetes Technol Ther. 2022 Apr;24(4):241-248. doi: 10.1089/dia.2021.0362. PMID: 34780283; PMCID: PMC9057870. 

  7. Suttiratana SC, Wong JJ, Lanning MS, Dunlap A, Hanes SJ, Hood KK, Lal RA, Naranjo D. Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery System. Diabetes Technol Ther. 2022 Jun;24(6):416-423. doi: 10.1089/dia.2021.0485. Epub 2022 May 12. PMID: 35099278; PMCID: PMC9208860. 

  8. Wong JJ, Hood KK, Hanes SJ, Lal RA, Naranjo D. Psychosocial Effects of the Loop Open-Source Automated Insulin Delivery System. J Diabetes Sci Technol. 2023 Nov;17(6):1440-1447. doi: 10.1177/19322968221105288. Epub 2022 Jun 30. PMID: 35771004; PMCID: PMC10658689. 

  9. Tanenbaum ML, Pang E, Tam R, Bishop FK, Prahalad P, Zaharieva DP, Addala A, Wong JJ, Naranjo D, Hood KK, Maahs DM. 'We're taught green is good': Perspectives on time in range and time in tight range from youth with type 1 diabetes, and parents of youth with type 1 diabetes. Diabet Med. 2024 Dec;41(12):e15423. doi: 10.1111/dme.15423. Epub 2024 Aug 8. PMID: 39118381; PMCID: PMC11560526.